cbd – Page 13 – cannabis.co.nz

May 5, 2022Africa, ambassador, analysis, analytics, athlete, blood, Boston, brand, business, cancer, cannabis, cbd, chemotherapy, consumer, dispensary, Edibles & Processing, Ethan Zohn, government, growing, industry, law, legalization, legalize, marathon, marijuana, market, massachusetts, medical, medicine, Momenta, player, product, Product Development, professional, Quality, recreational, regulatory, retail, runner, soccer, Sports, surviving, survivor, thc, Trulieve

A Q&A with Ethan Zohn, Brand Ambassador for Momenta, a Trulieve Brand

Cannabis has been used to treat symptoms of cancer and chemotherapy including severe and chronic pain, nausea and vomiting. Many athletes also […]

May 5, 2022Act, AML, analysis, analytics, bank, banking, BSA, business, Business Analysis, cannabis, cbd, CDD, civil, compliance, consumer, CRB, criminal, CSA, due diligence, EDD, Federal, finance, financial, government, growing, industry, lab, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, money, MORE, NBFI, penalties, product, recreational, regulation, regulations, regulatory, retail, risk, safe, schedule, transaction

Cannabis Banking: The Ins, the Outs & the Unknowns

As the legal cannabis market expands, banks and nonbank financial institutions (NBFIs) across the United States continue to explore how to safely […]

May 5, 20228, analysis, analytics, business, cannabidiol, cannabis, cbd, claim, compliance, consumer, cure, Delta, delta-8 THC, delta-8-tetrahydrocannabinol, delta-9 tetrahydrocannabinol, delta-9-THC, Dispensaries & Retail, drug, Edibles & Processing, FD&C act, FDA, Federal, government, growing, illegal, industry, lab, label, laboratories, laboratory, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, misbranded, prevent, product, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, treat, unapproved, update, violate, violation, warning

FDA Issues First Warning Letters for Delta-8 THC

In an unprecedented move, the U.S. Food & Drug Administration (FDA) has issued warning letters today to companies selling products containing delta-8 […]

April 27, 2022adult, aluminum, analysis, analytics, beverage, beverages, bottle, bottled, bottling, brand, branding, business, can, cannabis, cap, cbd, child, child-resistant, childproofing, closure, coffee, cola, compliance, compliant, consumer, Convenience, dispensary, drink, drinking, Edibles & Processing, fruity, glass, government, growing, HDPE, industry, labeling, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, material, package, packaged, packaging, PCR, pet, plastic, polypropylene, post-consumer, product, Product Development, proof, Quality, recreational, recycle, recycled, regulation, regulations, regulatory, retail, safety, sour, state, Sustainability, sweet, tea, test, Testing, thc, twist

Perfecting Your Packaging for Cannabis Beverages

Some consumers participating in the legal cannabis market want to avoid inhalable products. They are concerned about the effects of the smoke […]

April 26, 2022adult, alcohol, alcoholic, analysis, analytics, beverage, branding, business, california, CANADA, cannabis, cbd, compliance, consumer, Coors, dispensary, distribution, drink, Edibles & Processing, FDA, Federal, government, growing, Health, Inbev, industry, infused, lab, labeling, lagunitas, law, legal, legalization, legislation, license, manufacturing, marijuana, market, marketing, miller, Molson, MSO, multi state operator, pabst, packaging, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, shipping, sober, sobriety, sourcing, sparkling, state, test, Testing, thc, trademark, use, USPTO, water

The Rise of a New Market… And a New Consumer

The adult beverage industry, like any other category of consumer branded products, is driven by trends. If you’re old enough to remember […]

April 20, 2022action, analysis, analytics, approval, approved, business, Business Analysis, cannabidiol, cannabis, cbd, claim, compliance, Concentrates & Extracts, consumer, Coronavirus, COVID, COVID-19, cultivation, drug, Edibles & Processing, enforcement, extraction, farm bill, FD&C act, FDA, Federal, government, growing, Health, industry, lab, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, medical, medicine, New, product, Product Development, Quality, regulation, regulations, regulatory, research, retail, safety, state, test, Testing, thc, threaten, U.S. Food and Drug Administration, unapproved, unsubstantiated, warning, wellness

FDA Warning Letters: Stop Claiming CBD Prevents COVID

Once again, the U.S. Food and Drug Administration (FDA) has issued a number of warning letters to companies selling hemp-derived cannabidiol (CBD) […]